Viral Vector Packaging
Viral Vector Packaging is the construction and insertion of a target gene into the structural components of a virus, allowing the gene to replicate via viral replication. It is commonly used for gene therapy studies involving gene expression or knockout.
GENEWIZ Viral Vector Packaging services combine our 20 years of wet lab experience with our Ph.D.-level expertise to provide fast and reliable delivery of viral plasmids and particles. Ensuring effective delivery of your genes of interest (GOI) is the critical mission of viral packaging. Our project managers customize and scale your projects to meet the most rigorous technical requirements with the utmost quality.
Partnering with GENEWIZ can help your AAV, lentivirus, or baculovirus research succeed in making the world a healthier place for people everywhere.
Viral Vector Packaging Services
-
AAV Packaging
With low immunogenicity limiting the risk of integration into the host genome, adeno-associated viruses (AAVs) have emerged as promising vehicles to deliver both cell and gene therapies. These viruses, however do pose major challenges in both synthesis and packaging to obtain high titer and efficacy.
-
Lentivirus Packaging
Lentiviral vectors are research tools used to introduce gene products into in vitro systems, animal models, or human patients via gene therapy. Lentiviruses have a broad range of applications and are commonly used in clinical gene therapy as well as in CAR-T cell engineering.
-
Baculovirus Packaging
Baculovirus has been widely used to produce recombinant proteins on both insect and mammalian cells. The virus is an ideal tool for gene delivery and gene therapy due to its large gene capacity, which allows expression of proteins with large molecular weight, high safety through strict species specificity, high expression efficiency, and ease of amplification.
Plasmid Viral Packaging Features and Benefits
-
Reliable Provider: US-based protein production and reliable supply chain.
-
Rapid Turnaround: Industry-leading turnaround time starting at 4 weeks, from DNA synthesis to purified antibody.
-
Stringent QC: Multiple QC checkpoints, including protein concentration, aggregation, and purity.
-
Technical Support: Ph.D.-level consultation and support at every step of your project.
-
Complete Service Chain: Simplified project management with a single provider across all services including biobanking for long-term storage and inventory